Global Prostate Cancer Treatment Market Recent Trends, In-Depth Analysis, Industry Share, Size and Forecast 2022 To 2027

The Global Prostate Cancer Market is projected to grow at a CAGR of around 10.8% during the forecast period, i.e., 2022-27. Prostate cancer is one of the most common cancers in males worldwide. With its rising incidence, the demand for effective diagnosis & treatments is also surging rapidly and instigating the governments of different countries to increase their healthcare expenditures.

Top leading companies in the Global Prostate Cancer Treatment Market includes:

Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol Myers Squibb, Eisai Co. Ltd., Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Merck & Co., Inc., Novartis International AG, Pfizer Inc., Sanofi S.A., Others

Possible Restraint in the Global Prostate Cancer Market

The high costs associated with the tissue biopsy for prostate cancer, especially in cases of advanced-stage tumors, might restrain the fledged expansion of the Global Prostate Cancer Market during 2022-27. Besides, high consultation fees and poor reimbursement of treatment expenditures might also act as significant growth restraints for the market in the coming years..

Access the detailed PDF Sample report– https://www.marknteladvisors.com/query/request-sample/prostate-cancer-market.html

Report Segmentation:

The market is categorized into the following segments in the report:

By Diagnosis

-Tissue Biopsy

-Transrectal Ultrasound

-Prostate-specific Antigen Testing

-Urine Testing

-Imaging

By Treatment

-Surgery

-Radical Prostatectomy

-Cryotherapy

-Orchiectomy (Surgical Castration)

-Hormone Therapy

-LHRH (Luteinizing Hormone-Releasing Hormone) Agonists

– Leuprolide (Lupron, Eligard)

-Goserelin (Zoladex)

-Triptorelin (Trelstar)

-Leuprolide mesylate (Camcevi)

-LHRH (Luteinizing Hormone-Releasing Hormone) Antagonists

-Degarelix (Firmagon)

-Relugolix (Orgovyx)

-Radiation Therapy

-External Beam Radiation Therapy (EBRT)

-Proton Beam Radiation Therapy

-Three-Dimensional Conformal Radiation Therapy (3D-CRT)

-Stereotactic Body Radiation Therapy (SBRT)

-Brachytherapy (Internal Radiation Therapy)

-Radiopharmaceuticals

-Chemotherapy

-Docetaxel (Taxotere)

-Cabazitaxel (Jevtana)

-Mitoxantrone (Novantrone)

-Estramustine (Emcyt)

-Targeted Therapy

-Rucaparib (Rubraca)

-Olaparib (Lynparza)

By End-User

-Hospitals

-Clinics

By Region

-North America

-South America

-Europe

-Middle East & Africa

-Asia-Pacific.

Explore Our Comprehensive Study Reports – https://www.marknteladvisors.com/research-library/prostate-cancer-market.html

Global Prostate Cancer Treatment Market Geographic Reach:

The Geographic Reach of the Global Prostate Cancer Treatment Market evaluates the spread and significance of Global Prostate Cancer Treatment market consumption across different regions/country, emphasizing areas with the largest market size and the most promising growth potential.

• North America: The US, Canada, Mexico
• Europe: Germany, The UK, Germany, France, Italy, Spain, Rest of Europe
• Asia-Pacific: China, Japan, India, Australia, South East Asia, Rest of Asia-Pacific
• South America: Brazil, Rest of Latin America
• Middle East & Africa: South Africa, GCC, Rest of Middle East & Africa.

Note: If you require specific information not covered in the current report, we can provide it through customized option

Why choose Us?

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

Contact Us –

Call: 📞 +1 628 895 8081 +91 120 4278433

Email: 📧 sales@marknteladvisors.com

Visit to know more: 🌐 https://www.marknteladvisors.com